These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 16353208
1. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N. Cancer; 2006 Jan 15; 106(2):466-73. PubMed ID: 16353208 [Abstract] [Full Text] [Related]
2. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal BH, Killar J, Taylor A, Kartsonis N, Patterson TF, Aoun M, Caillot D, Sable C, Caspofungin Combination Therapy Study Group. Cancer; 2006 Dec 15; 107(12):2888-97. PubMed ID: 17103444 [Abstract] [Full Text] [Related]
3. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Zaoutis TE, Jafri HS, Huang LM, Locatelli F, Barzilai A, Ebell W, Steinbach WJ, Bradley J, Lieberman JM, Hsiao CC, Seibel N, Laws HJ, Gamba M, Petrecz M, Taylor AF, Strohmaier KM, Chow JW, Kartsonis NA, Ngai AL. Pediatrics; 2009 Mar 15; 123(3):877-84. PubMed ID: 19255017 [Abstract] [Full Text] [Related]
5. Comparison of caspofungin and amphotericin B for invasive candidiasis. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J, Caspofungin Invasive Candidiasis Study Group. N Engl J Med; 2002 Dec 19; 347(25):2020-9. PubMed ID: 12490683 [Abstract] [Full Text] [Related]
6. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. Keating G, Figgitt D. Drugs; 2003 Dec 19; 63(20):2235-63. PubMed ID: 14498760 [Abstract] [Full Text] [Related]
7. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study). Jarque I, Tormo M, Bello JL, Rovira M, Batlle M, Julià A, Tabares S, Rivas C, Fernández-Sevilla A, García-Boyero R, Debén G, González-Campos J, Capote FJ, Sanz MA, Spanish Pethema Group. Med Mycol; 2013 Feb 19; 51(2):150-4. PubMed ID: 22712457 [Abstract] [Full Text] [Related]
9. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL, Perry CM. Drugs; 2005 Feb 19; 65(14):2049-68. PubMed ID: 16162025 [Abstract] [Full Text] [Related]
10. Caspofungin for the treatment of less common forms of invasive candidiasis. Cornely OA, Lasso M, Betts R, Klimko N, Vazquez J, Dobb G, Velez J, Williams-Diaz A, Lipka J, Taylor A, Sable C, Kartsonis N. J Antimicrob Chemother; 2007 Aug 19; 60(2):363-9. PubMed ID: 17526917 [Abstract] [Full Text] [Related]
12. Efficacy and safety of caspofungin in solid organ transplant recipients. Petrovic J, Ngai A, Bradshaw S, Williams-Diaz A, Taylor A, Sable C, Vuocolo S, Kartsonis N. Transplant Proc; 2007 Dec 19; 39(10):3117-20. PubMed ID: 18089335 [Abstract] [Full Text] [Related]
16. The pharmacology and clinical use of caspofungin. Hope WW, Shoham S, Walsh TJ. Expert Opin Drug Metab Toxicol; 2007 Apr 19; 3(2):263-74. PubMed ID: 17428155 [Abstract] [Full Text] [Related]